nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—Amprenavir—acquired immunodeficiency syndrome	0.489	1	CrCtD
Fosamprenavir—Darunavir—Amprenavir—acquired immunodeficiency syndrome	0.286	1	CrCrCtD
Fosamprenavir—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0161	0.126	CbGbCtD
Fosamprenavir—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0151	0.119	CbGbCtD
Fosamprenavir—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0151	0.119	CbGbCtD
Fosamprenavir—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0137	0.107	CbGbCtD
Fosamprenavir—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0137	0.107	CbGbCtD
Fosamprenavir—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0118	0.0925	CbGbCtD
Fosamprenavir—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0115	0.0898	CbGbCtD
Fosamprenavir—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0104	0.0812	CbGbCtD
Fosamprenavir—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0104	0.0812	CbGbCtD
Fosamprenavir—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00995	0.0779	CbGbCtD
Fosamprenavir—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	4.46e-05	0.000461	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	4.46e-05	0.00046	CcSEcCtD
Fosamprenavir—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	4.46e-05	0.00046	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	4.45e-05	0.000459	CcSEcCtD
Fosamprenavir—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	4.45e-05	0.000459	CcSEcCtD
Fosamprenavir—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	4.44e-05	0.000458	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	4.43e-05	0.000457	CcSEcCtD
Fosamprenavir—Pruritus—Amprenavir—acquired immunodeficiency syndrome	4.43e-05	0.000457	CcSEcCtD
Fosamprenavir—Fatigue—Nevirapine—acquired immunodeficiency syndrome	4.42e-05	0.000457	CcSEcCtD
Fosamprenavir—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	4.37e-05	0.000452	CcSEcCtD
Fosamprenavir—Flatulence—Delavirdine—acquired immunodeficiency syndrome	4.37e-05	0.000451	CcSEcCtD
Fosamprenavir—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	4.32e-05	0.000446	CcSEcCtD
Fosamprenavir—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	4.31e-05	0.000445	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	4.29e-05	0.000443	CcSEcCtD
Fosamprenavir—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	4.29e-05	0.000443	CcSEcCtD
Fosamprenavir—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	4.28e-05	0.000442	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	4.28e-05	0.000442	CcSEcCtD
Fosamprenavir—Fatigue—Stavudine—acquired immunodeficiency syndrome	4.27e-05	0.000441	CcSEcCtD
Fosamprenavir—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	4.26e-05	0.00044	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	4.25e-05	0.000439	CcSEcCtD
Fosamprenavir—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	4.24e-05	0.000438	CcSEcCtD
Fosamprenavir—Angioedema—Efavirenz—acquired immunodeficiency syndrome	4.24e-05	0.000437	CcSEcCtD
Fosamprenavir—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	4.22e-05	0.000436	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	4.21e-05	0.000435	CcSEcCtD
Fosamprenavir—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	4.21e-05	0.000435	CcSEcCtD
Fosamprenavir—Fatigue—Abacavir—acquired immunodeficiency syndrome	4.21e-05	0.000435	CcSEcCtD
Fosamprenavir—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	4.21e-05	0.000434	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	4.2e-05	0.000433	CcSEcCtD
Fosamprenavir—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	4.18e-05	0.000432	CcSEcCtD
Fosamprenavir—Myalgia—Indinavir—acquired immunodeficiency syndrome	4.18e-05	0.000431	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	4.15e-05	0.000428	CcSEcCtD
Fosamprenavir—Anorexia—Zidovudine—acquired immunodeficiency syndrome	4.11e-05	0.000424	CcSEcCtD
Fosamprenavir—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	4.1e-05	0.000424	CcSEcCtD
Fosamprenavir—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	4.1e-05	0.000423	CcSEcCtD
Fosamprenavir—Asthenia—Didanosine—acquired immunodeficiency syndrome	4.09e-05	0.000423	CcSEcCtD
Fosamprenavir—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	4.09e-05	0.000422	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	4.06e-05	0.00042	CcSEcCtD
Fosamprenavir—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	4.06e-05	0.000419	CcSEcCtD
Fosamprenavir—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	4.06e-05	0.000419	CcSEcCtD
Fosamprenavir—Angioedema—Delavirdine—acquired immunodeficiency syndrome	4.05e-05	0.000419	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	4.05e-05	0.000418	CcSEcCtD
Fosamprenavir—Flatulence—Ritonavir—acquired immunodeficiency syndrome	4.04e-05	0.000417	CcSEcCtD
Fosamprenavir—Pruritus—Didanosine—acquired immunodeficiency syndrome	4.04e-05	0.000417	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	3.99e-05	0.000412	CcSEcCtD
Fosamprenavir—Vomiting—Amprenavir—acquired immunodeficiency syndrome	3.98e-05	0.000411	CcSEcCtD
Fosamprenavir—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	3.95e-05	0.000408	CcSEcCtD
Fosamprenavir—Myalgia—Efavirenz—acquired immunodeficiency syndrome	3.95e-05	0.000408	CcSEcCtD
Fosamprenavir—Rash—Amprenavir—acquired immunodeficiency syndrome	3.95e-05	0.000408	CcSEcCtD
Fosamprenavir—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	3.94e-05	0.000407	CcSEcCtD
Fosamprenavir—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	3.93e-05	0.000406	CcSEcCtD
Fosamprenavir—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	3.93e-05	0.000406	CcSEcCtD
Fosamprenavir—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	3.93e-05	0.000406	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	3.92e-05	0.000405	CcSEcCtD
Fosamprenavir—Headache—Amprenavir—acquired immunodeficiency syndrome	3.92e-05	0.000405	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	3.92e-05	0.000405	CcSEcCtD
Fosamprenavir—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	3.92e-05	0.000404	CcSEcCtD
Fosamprenavir—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	3.92e-05	0.000404	CcSEcCtD
Fosamprenavir—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	3.91e-05	0.000404	CcSEcCtD
Fosamprenavir—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	3.91e-05	0.000403	CcSEcCtD
Fosamprenavir—Flatulence—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000402	CcSEcCtD
Fosamprenavir—Skin disorder—Indinavir—acquired immunodeficiency syndrome	3.89e-05	0.000402	CcSEcCtD
Fosamprenavir—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	3.86e-05	0.000398	CcSEcCtD
Fosamprenavir—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	3.86e-05	0.000398	CcSEcCtD
Fosamprenavir—Anorexia—Indinavir—acquired immunodeficiency syndrome	3.82e-05	0.000394	CcSEcCtD
Fosamprenavir—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	3.78e-05	0.00039	CcSEcCtD
Fosamprenavir—Myalgia—Delavirdine—acquired immunodeficiency syndrome	3.78e-05	0.00039	CcSEcCtD
Fosamprenavir—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	3.77e-05	0.000389	CcSEcCtD
Fosamprenavir—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	3.74e-05	0.000387	CcSEcCtD
Fosamprenavir—Nausea—Amprenavir—acquired immunodeficiency syndrome	3.72e-05	0.000384	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	3.72e-05	0.000384	CcSEcCtD
Fosamprenavir—Fatigue—Zidovudine—acquired immunodeficiency syndrome	3.71e-05	0.000383	CcSEcCtD
Fosamprenavir—Flatulence—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000383	CcSEcCtD
Fosamprenavir—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	3.71e-05	0.000383	CcSEcCtD
Fosamprenavir—Asthenia—Nevirapine—acquired immunodeficiency syndrome	3.68e-05	0.00038	CcSEcCtD
Fosamprenavir—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	3.68e-05	0.00038	CcSEcCtD
Fosamprenavir—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	3.66e-05	0.000378	CcSEcCtD
Fosamprenavir—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	3.65e-05	0.000377	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	3.65e-05	0.000377	CcSEcCtD
Fosamprenavir—Pruritus—Nevirapine—acquired immunodeficiency syndrome	3.63e-05	0.000375	CcSEcCtD
Fosamprenavir—Vomiting—Didanosine—acquired immunodeficiency syndrome	3.63e-05	0.000375	CcSEcCtD
Fosamprenavir—Anorexia—Efavirenz—acquired immunodeficiency syndrome	3.61e-05	0.000372	CcSEcCtD
Fosamprenavir—Rash—Didanosine—acquired immunodeficiency syndrome	3.6e-05	0.000372	CcSEcCtD
Fosamprenavir—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	3.6e-05	0.000371	CcSEcCtD
Fosamprenavir—Dermatitis—Didanosine—acquired immunodeficiency syndrome	3.6e-05	0.000371	CcSEcCtD
Fosamprenavir—Headache—Didanosine—acquired immunodeficiency syndrome	3.58e-05	0.000369	CcSEcCtD
Fosamprenavir—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	3.57e-05	0.000368	CcSEcCtD
Fosamprenavir—Asthenia—Stavudine—acquired immunodeficiency syndrome	3.56e-05	0.000367	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	3.52e-05	0.000364	CcSEcCtD
Fosamprenavir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	3.52e-05	0.000363	CcSEcCtD
Fosamprenavir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	3.52e-05	0.000363	CcSEcCtD
Fosamprenavir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	3.51e-05	0.000363	CcSEcCtD
Fosamprenavir—Pruritus—Stavudine—acquired immunodeficiency syndrome	3.51e-05	0.000362	CcSEcCtD
Fosamprenavir—Asthenia—Abacavir—acquired immunodeficiency syndrome	3.5e-05	0.000362	CcSEcCtD
Fosamprenavir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	3.49e-05	0.000361	CcSEcCtD
Fosamprenavir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	3.48e-05	0.00036	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	3.47e-05	0.000358	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	3.46e-05	0.000357	CcSEcCtD
Fosamprenavir—Pruritus—Abacavir—acquired immunodeficiency syndrome	3.45e-05	0.000357	CcSEcCtD
Fosamprenavir—Fatigue—Indinavir—acquired immunodeficiency syndrome	3.45e-05	0.000357	CcSEcCtD
Fosamprenavir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	3.45e-05	0.000356	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	3.45e-05	0.000356	CcSEcCtD
Fosamprenavir—Angioedema—Lamivudine—acquired immunodeficiency syndrome	3.44e-05	0.000355	CcSEcCtD
Fosamprenavir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	3.4e-05	0.000352	CcSEcCtD
Fosamprenavir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	3.4e-05	0.000352	CcSEcCtD
Fosamprenavir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	3.4e-05	0.000351	CcSEcCtD
Fosamprenavir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	3.39e-05	0.00035	CcSEcCtD
Fosamprenavir—Nausea—Didanosine—acquired immunodeficiency syndrome	3.39e-05	0.00035	CcSEcCtD
Fosamprenavir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	3.36e-05	0.000347	CcSEcCtD
Fosamprenavir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	3.34e-05	0.000345	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	3.34e-05	0.000345	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	3.3e-05	0.000341	CcSEcCtD
Fosamprenavir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	3.29e-05	0.00034	CcSEcCtD
Fosamprenavir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	3.29e-05	0.000339	CcSEcCtD
Fosamprenavir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	3.28e-05	0.000339	CcSEcCtD
Fosamprenavir—Dizziness—Stavudine—acquired immunodeficiency syndrome	3.28e-05	0.000338	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	3.28e-05	0.000338	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	3.27e-05	0.000337	CcSEcCtD
Fosamprenavir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	3.26e-05	0.000337	CcSEcCtD
Fosamprenavir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	3.26e-05	0.000337	CcSEcCtD
Fosamprenavir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	3.25e-05	0.000336	CcSEcCtD
Fosamprenavir—Rash—Nevirapine—acquired immunodeficiency syndrome	3.24e-05	0.000334	CcSEcCtD
Fosamprenavir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	3.23e-05	0.000334	CcSEcCtD
Fosamprenavir—Dizziness—Abacavir—acquired immunodeficiency syndrome	3.23e-05	0.000333	CcSEcCtD
Fosamprenavir—Headache—Nevirapine—acquired immunodeficiency syndrome	3.22e-05	0.000332	CcSEcCtD
Fosamprenavir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	3.21e-05	0.000331	CcSEcCtD
Fosamprenavir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	3.19e-05	0.00033	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	3.19e-05	0.000329	CcSEcCtD
Fosamprenavir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	3.17e-05	0.000327	CcSEcCtD
Fosamprenavir—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	3.17e-05	0.000327	CcSEcCtD
Fosamprenavir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	3.16e-05	0.000326	CcSEcCtD
Fosamprenavir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	3.16e-05	0.000326	CcSEcCtD
Fosamprenavir—Vomiting—Stavudine—acquired immunodeficiency syndrome	3.15e-05	0.000325	CcSEcCtD
Fosamprenavir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	3.15e-05	0.000325	CcSEcCtD
Fosamprenavir—Rash—Nelfinavir—acquired immunodeficiency syndrome	3.13e-05	0.000324	CcSEcCtD
Fosamprenavir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	3.13e-05	0.000323	CcSEcCtD
Fosamprenavir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	3.13e-05	0.000323	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	3.13e-05	0.000323	CcSEcCtD
Fosamprenavir—Rash—Stavudine—acquired immunodeficiency syndrome	3.12e-05	0.000323	CcSEcCtD
Fosamprenavir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	3.12e-05	0.000322	CcSEcCtD
Fosamprenavir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	3.12e-05	0.000322	CcSEcCtD
Fosamprenavir—Headache—Nelfinavir—acquired immunodeficiency syndrome	3.11e-05	0.000322	CcSEcCtD
Fosamprenavir—Headache—Stavudine—acquired immunodeficiency syndrome	3.1e-05	0.000321	CcSEcCtD
Fosamprenavir—Vomiting—Abacavir—acquired immunodeficiency syndrome	3.1e-05	0.00032	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	3.09e-05	0.00032	CcSEcCtD
Fosamprenavir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	3.09e-05	0.000319	CcSEcCtD
Fosamprenavir—Rash—Abacavir—acquired immunodeficiency syndrome	3.08e-05	0.000318	CcSEcCtD
Fosamprenavir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	3.07e-05	0.000318	CcSEcCtD
Fosamprenavir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	3.07e-05	0.000317	CcSEcCtD
Fosamprenavir—Headache—Abacavir—acquired immunodeficiency syndrome	3.06e-05	0.000316	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	3.05e-05	0.000315	CcSEcCtD
Fosamprenavir—Nausea—Nevirapine—acquired immunodeficiency syndrome	3.05e-05	0.000315	CcSEcCtD
Fosamprenavir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	3.05e-05	0.000315	CcSEcCtD
Fosamprenavir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	3.02e-05	0.000311	CcSEcCtD
Fosamprenavir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	2.99e-05	0.000309	CcSEcCtD
Fosamprenavir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	2.99e-05	0.000309	CcSEcCtD
Fosamprenavir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	2.99e-05	0.000308	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	2.96e-05	0.000306	CcSEcCtD
Fosamprenavir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	2.95e-05	0.000305	CcSEcCtD
Fosamprenavir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	2.95e-05	0.000305	CcSEcCtD
Fosamprenavir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	2.95e-05	0.000304	CcSEcCtD
Fosamprenavir—Nausea—Stavudine—acquired immunodeficiency syndrome	2.94e-05	0.000304	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	2.94e-05	0.000303	CcSEcCtD
Fosamprenavir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	2.93e-05	0.000303	CcSEcCtD
Fosamprenavir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	2.91e-05	0.000301	CcSEcCtD
Fosamprenavir—Nausea—Abacavir—acquired immunodeficiency syndrome	2.9e-05	0.000299	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	2.89e-05	0.000298	CcSEcCtD
Fosamprenavir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	2.89e-05	0.000298	CcSEcCtD
Fosamprenavir—Asthenia—Indinavir—acquired immunodeficiency syndrome	2.87e-05	0.000297	CcSEcCtD
Fosamprenavir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	2.86e-05	0.000296	CcSEcCtD
Fosamprenavir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	2.86e-05	0.000296	CcSEcCtD
Fosamprenavir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	2.85e-05	0.000294	CcSEcCtD
Fosamprenavir—Pruritus—Indinavir—acquired immunodeficiency syndrome	2.83e-05	0.000293	CcSEcCtD
Fosamprenavir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	2.8e-05	0.000289	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	2.8e-05	0.000289	CcSEcCtD
Fosamprenavir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	2.79e-05	0.000288	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	2.78e-05	0.000287	CcSEcCtD
Fosamprenavir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	2.78e-05	0.000287	CcSEcCtD
Fosamprenavir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	2.74e-05	0.000283	CcSEcCtD
Fosamprenavir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	2.74e-05	0.000283	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	2.74e-05	0.000283	CcSEcCtD
Fosamprenavir—Rash—Zidovudine—acquired immunodeficiency syndrome	2.72e-05	0.00028	CcSEcCtD
Fosamprenavir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	2.72e-05	0.00028	CcSEcCtD
Fosamprenavir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	2.71e-05	0.00028	CcSEcCtD
Fosamprenavir—Headache—Zidovudine—acquired immunodeficiency syndrome	2.7e-05	0.000279	CcSEcCtD
Fosamprenavir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	2.68e-05	0.000276	CcSEcCtD
Fosamprenavir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	2.67e-05	0.000276	CcSEcCtD
Fosamprenavir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	2.67e-05	0.000275	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	2.65e-05	0.000274	CcSEcCtD
Fosamprenavir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	2.65e-05	0.000274	CcSEcCtD
Fosamprenavir—Dizziness—Indinavir—acquired immunodeficiency syndrome	2.65e-05	0.000273	CcSEcCtD
Fosamprenavir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	2.65e-05	0.000273	CcSEcCtD
Fosamprenavir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	2.65e-05	0.000273	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	2.64e-05	0.000272	CcSEcCtD
Fosamprenavir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	2.6e-05	0.000268	CcSEcCtD
Fosamprenavir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	2.59e-05	0.000267	CcSEcCtD
Fosamprenavir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	2.56e-05	0.000265	CcSEcCtD
Fosamprenavir—Nausea—Zidovudine—acquired immunodeficiency syndrome	2.56e-05	0.000264	CcSEcCtD
Fosamprenavir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	2.55e-05	0.000263	CcSEcCtD
Fosamprenavir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	2.55e-05	0.000263	CcSEcCtD
Fosamprenavir—Vomiting—Indinavir—acquired immunodeficiency syndrome	2.55e-05	0.000263	CcSEcCtD
Fosamprenavir—Rash—Indinavir—acquired immunodeficiency syndrome	2.53e-05	0.000261	CcSEcCtD
Fosamprenavir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	2.52e-05	0.000261	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	2.51e-05	0.00026	CcSEcCtD
Fosamprenavir—Headache—Indinavir—acquired immunodeficiency syndrome	2.51e-05	0.000259	CcSEcCtD
Fosamprenavir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	2.5e-05	0.000258	CcSEcCtD
Fosamprenavir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	2.48e-05	0.000256	CcSEcCtD
Fosamprenavir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	2.47e-05	0.000255	CcSEcCtD
Fosamprenavir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	2.43e-05	0.000251	CcSEcCtD
Fosamprenavir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	2.43e-05	0.000251	CcSEcCtD
Fosamprenavir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	2.41e-05	0.000248	CcSEcCtD
Fosamprenavir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	2.4e-05	0.000248	CcSEcCtD
Fosamprenavir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	2.39e-05	0.000247	CcSEcCtD
Fosamprenavir—Rash—Efavirenz—acquired immunodeficiency syndrome	2.39e-05	0.000246	CcSEcCtD
Fosamprenavir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	2.38e-05	0.000246	CcSEcCtD
Fosamprenavir—Nausea—Indinavir—acquired immunodeficiency syndrome	2.38e-05	0.000246	CcSEcCtD
Fosamprenavir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	2.37e-05	0.000245	CcSEcCtD
Fosamprenavir—Headache—Efavirenz—acquired immunodeficiency syndrome	2.37e-05	0.000245	CcSEcCtD
Fosamprenavir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	2.37e-05	0.000245	CcSEcCtD
Fosamprenavir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	2.31e-05	0.000239	CcSEcCtD
Fosamprenavir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	2.3e-05	0.000238	CcSEcCtD
Fosamprenavir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	2.29e-05	0.000237	CcSEcCtD
Fosamprenavir—Rash—Delavirdine—acquired immunodeficiency syndrome	2.28e-05	0.000236	CcSEcCtD
Fosamprenavir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	2.28e-05	0.000236	CcSEcCtD
Fosamprenavir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	2.28e-05	0.000235	CcSEcCtD
Fosamprenavir—Headache—Delavirdine—acquired immunodeficiency syndrome	2.27e-05	0.000234	CcSEcCtD
Fosamprenavir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	2.27e-05	0.000234	CcSEcCtD
Fosamprenavir—Nausea—Efavirenz—acquired immunodeficiency syndrome	2.25e-05	0.000232	CcSEcCtD
Fosamprenavir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	2.21e-05	0.000229	CcSEcCtD
Fosamprenavir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	2.21e-05	0.000228	CcSEcCtD
Fosamprenavir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	2.21e-05	0.000228	CcSEcCtD
Fosamprenavir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	2.18e-05	0.000225	CcSEcCtD
Fosamprenavir—Nausea—Delavirdine—acquired immunodeficiency syndrome	2.15e-05	0.000222	CcSEcCtD
Fosamprenavir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	2.13e-05	0.00022	CcSEcCtD
Fosamprenavir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	2.13e-05	0.00022	CcSEcCtD
Fosamprenavir—Rash—Ritonavir—acquired immunodeficiency syndrome	2.11e-05	0.000218	CcSEcCtD
Fosamprenavir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	2.11e-05	0.000218	CcSEcCtD
Fosamprenavir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	2.1e-05	0.000217	CcSEcCtD
Fosamprenavir—Headache—Ritonavir—acquired immunodeficiency syndrome	2.1e-05	0.000217	CcSEcCtD
Fosamprenavir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	2.05e-05	0.000212	CcSEcCtD
Fosamprenavir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	2.03e-05	0.00021	CcSEcCtD
Fosamprenavir—Rash—Saquinavir—acquired immunodeficiency syndrome	2.03e-05	0.00021	CcSEcCtD
Fosamprenavir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.03e-05	0.00021	CcSEcCtD
Fosamprenavir—Headache—Saquinavir—acquired immunodeficiency syndrome	2.02e-05	0.000208	CcSEcCtD
Fosamprenavir—Nausea—Ritonavir—acquired immunodeficiency syndrome	1.99e-05	0.000205	CcSEcCtD
Fosamprenavir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	1.95e-05	0.000202	CcSEcCtD
Fosamprenavir—Rash—Lamivudine—acquired immunodeficiency syndrome	1.94e-05	0.0002	CcSEcCtD
Fosamprenavir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	1.94e-05	0.0002	CcSEcCtD
Fosamprenavir—Headache—Lamivudine—acquired immunodeficiency syndrome	1.93e-05	0.000199	CcSEcCtD
Fosamprenavir—Nausea—Saquinavir—acquired immunodeficiency syndrome	1.91e-05	0.000198	CcSEcCtD
Fosamprenavir—Nausea—Lamivudine—acquired immunodeficiency syndrome	1.83e-05	0.000189	CcSEcCtD
